ketoconazole + dexamethasone + testosterone + GnRH

This is a combination regimen consisting of four pharmacologically distinct agents: - **Ketoconazole** is an imidazole antifungal that also inhibits steroidogenesis by blocking enzymes such as 17,20-lyase, leading to reduced testosterone synthesis. - **Dexamethasone** is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties; it also suppresses the hypothalamic-pituitary-adrenal (HPA) axis and can reduce endogenous ACTH production. - **Testosterone** is the primary male sex hormone and anabolic steroid, responsible for the development of male reproductive tissues and secondary sexual characteristics. - **GnRH (Gonadotropin-releasing hormone)** regulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. Agonists or antagonists are used clinically to suppress gonadal function. The combination has been studied in research settings to manipulate androgen levels through multiple mechanisms—suppression of gonadotropins with GnRH analogs/antagonists, inhibition of testicular steroidogenesis with ketoconazole, modulation of feedback via exogenous testosterone administration, and suppression of adrenal steroids with dexamethasone. This approach allows for precise control over intratesticular and systemic androgen concentrations for experimental or therapeutic purposes[1][3][4]. It does not correspond to any approved commercial product but represents a multi-drug protocol used in endocrine research.